Chase Investment Counsel Corp Innoviva, Inc. Transaction History
Chase Investment Counsel Corp
- $296 Million
- Q3 2024
A detailed history of Chase Investment Counsel Corp transactions in Innoviva, Inc. stock. As of the latest transaction made, Chase Investment Counsel Corp holds 80,000 shares of INVA stock, worth $1.42 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
80,000
Previous 80,000
-0.0%
Holding current value
$1.42 Million
Previous $1.31 Million
17.68%
% of portfolio
0.52%
Previous 0.47%
Shares
5 transactions
Others Institutions Holding INVA
# of Institutions
227Shares Held
78.9MCall Options Held
37.6KPut Options Held
300-
Black Rock Inc. New York, NY9.63MShares$171 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$129 Million34.93% of portfolio
-
Franklin Resources Inc San Mateo, CA6.75MShares$120 Million0.04% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$112 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.23MShares$111 Million0.0% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.24B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...